Skip to content
PeptideAgent

Compounding pharmacies in Oregon

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The Oregon Board of Pharmacy regulates compounding pharmacies in Oregon. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Oregon at a glance

Pharmacy regulator
Oregon Board of Pharmacy
503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Oregon

No verified compounding pharmacies serving Oregon are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Oregon

The Oregon Board of Pharmacy registers drug outlets under ORS chapter 689: ORS 689.005 defines a drug outlet to include any establishment with facilities located within or out of Oregon that dispenses or delivers drugs in Oregon, and ORS 689.305 requires all drug outlets to register annually. OAR 855-041-1060 requires every non-resident pharmacy that provides drugs or services to a person in Oregon to register with the Board, to be registered in its home state, and to designate an Oregon-licensed pharmacist-in-charge. Compounding is governed by OAR chapter 855, division 183 (Drug Compounding), adopted effective June 17, 2026 in place of the former division 45. OAR 855-183-0001 applies the division to sterile and non-sterile compounding and requires any entity inside or outside Oregon that compounds for dispensing or delivery in Oregon to register as a drug outlet; OAR 855-183-0015 requires compliance with USP chapters 795, 797, and 800 and, from November 1, 2027, requires non-resident outlets that compound to show home-state inspection against current USP standards or an approved accreditation. Oregon has not created a state bulks list; eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [2] [3] [4] [5]

Compounded GLP-1 access in Oregon

Telehealth GLP-1 patients should confirm the dispensing pharmacy appears in the Board of Pharmacy license lookup. [1] [8]

Research use only sellers in Oregon

ORS chapter 689 restricts dispensing of prescription drugs to registered pharmacies and licensed practitioners, and a seller of "research use only" injectable peptides to Oregon consumers is not a registered drug outlet. Oregon's Unlawful Trade Practices Act (ORS 646.608) also reaches misleading health claims made to consumers. [2] [9]

How to check a compounding pharmacy in Oregon

  1. Search the Oregon Board of Pharmacy license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Oregon requires before it ships to you. [1] [2] [3] [4] [5]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Oregon. [2] [9]

Common questions in Oregon

How do I check whether a mail-order pharmacy can ship compounded peptides to Oregon?

Search the Oregon Board of Pharmacy license lookup for the pharmacy. Under ORS 689.305 and OAR 855-041-1060 an out-of-state pharmacy must register with the Board as a non-resident pharmacy before shipping to Oregon patients. If the pharmacy is not listed, the shipment is not lawful in Oregon even if the prescriber is compliant. [1] [2] [3]

Can an Oregon pharmacy compound BPC-157 or other unapproved peptides?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [4] [6] [7]

All peptide legal questions for Oregon

Sources

  1. [1]Oregon Board of Pharmacy
  2. [2]ORS chapter 689, Pharmacists; Drug Outlets; Drug Sales
  3. [3]Oregon Administrative Rule 855-041-1060, Non-Resident Pharmacies
  4. [4]Oregon Administrative Rules chapter 855, division 183, Drug Compounding (Oregon Board of Pharmacy, effective June 17, 2026)
  5. [5]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  6. [6]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  7. [7]FDA: Pharmacy Compounding Advisory CommitteeFDA
  8. [8]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  9. [9]21 U.S.C. 331, Prohibited acts